Reinfection in American Cutaneous Leishmaniasis: Evaluation of Clinical Outcomes in the Hamster Model

Memorias do Instituto Oswaldo Cruz

Volumn 93, Issue 3, 1998, Pages 353-356

  Osorio, Y ^b   Gonzalez, S J ^a   Gama, V L ^a   Travi, B L ^b  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

^b CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

Author keywords

Hamster; Immunoprophylaxis; Leishmania major; Leishmania panamensis; Reinfection

Indexed keywords

ANIMALIA; CRICETINAE; LEISHMANIA MAJOR; LEISHMANIA PANAMENSIS;

ANIMAL; ARTICLE; DISEASE MODEL; HAMSTER; IMMUNOLOGY; LEISHMANIA; LEISHMANIA MAJOR; PARASITOLOGY; RECURRENT DISEASE; SKIN LEISHMANIASIS; TIME;

ANIMALS; CRICETINAE; DISEASE MODELS, ANIMAL; LEISHMANIA GUYANENSIS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; RECURRENCE; TIME FACTORS;

EID: 0032065254     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761998000300015     Document Type: Review

References (17)

1. Aebischer T 1994. Recurrent cutaneous leishmaniasis: A role for persistent parasites? Parasitai Today 10: 25-28.
2. Aragort R, Rossell O, De Jesús R, Rodriguez AM 1993. Thermotherapy v. antimonials: what happens after the healing of cutaneous leishmaniasis lesions? Ann Trop Med Parasitol 87: 23-30.
3. Beacham B, Romito R, Kay D 1982.Vaccination of the african white-tailed rat, Mystromys albacaudatus, with sonicated Leishmania braziliensis panamensis promastigotes. Am J Trop Med Hyg 31: 252-258.
4. Bienzle U, Ebert F, Dietrich M 1978. Cutaneous leishmaniasis in Eastern Saudi Arabia. Epidemiological and clinical features in a non-immune population living in an endemic area. Tropen Med Parasitol 29:188-193.
5. Cuba-Cuba CA, Marsden PD 1993. Marmosets in New World leishmaniasis research. Medicina (Buenos Aires) 53: 419-423.
6. Greenblatt CL 1988. Cutaneous leishmaniasis: the prospects for a killed vaccine. Parasitol Today 4: 53-54.
7. Killick-Kendrick R, Bryceson ADM, Peters W, Evans DA, Leaney AJ, Rioux JA 1985. Zoonotic cutaneous leishmaniasis in Saudi Arabia: lesions healing naturally in man followed by second infection with the same zymodeme of Leishmania major. Trans R Soc Trop Med Hyg 79: 363-355.
8. Marsden PD 1986. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg 80: 859-876.
9. Mitchell GF, Curtis JM, Hanman E 1981. Resistance to cutaneous leishmaniasis in genetically susceptible BALB/c mice. Aust J Exp Biol Med Sc 59: 555.
10. Modabber F 1990. Development of vaccines against leishmaniasis. Scand J Infect Dis 76: 72-78.
11. Moll H, Flohe S, Rollinghoff M 1995. Dendritic cells in Leishmania major immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Imm 25: 693-699.
12. Neal RA, Reeves A, Peters W 1990. Leishmania infecting man and wild animals in Saudi Arabia 7. Partial protection of mice against Leishmania major by prior infection with L. arabica. Trans R Soc Trop Med Hyg 84: 233-238.
13. Pérez H, Arredondo B, Machado R 1979. Leishmania mexicana and Leishmania tropica: cross immunity in C57BL/6 mice. Exp Parasitol 48: 9-14.
14. Rivier D, Shah R, Bovay P, Mauel J 1993. Vaccine development against cutaneous leishmaniasis. Subcutaneous administration of radioattenuated parasites protects CBA mice against virulent Leishmania major challenge. Parasite Immunol 15: 75-84.
15. Saravia NG, Weigle K, Segura I, Holmes S, Pacheco R, Labrada LA, Gonçalves A 1990. Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection? The Lancet 336: 398-402.
16. Sebai ZA, Morsy TA 1976. Cutaneous leishmaniasis in Bisha Town, Saudi Arabia. J Trop Med Hyg 79: 89-91.
17. Weigle KA, Santrich C, Martinez F, Valderrama L, Saravia NG 1993. Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations. J Inf Dis 168: 699-708.